Venalafaxine Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Extended-Release (ER) Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the controlled-release polymer matrix.
Active Ingredient Strength Primary Clinical Use Venlafaxine Hydrochloride USP/BP/Ph.Eur. 37.5 mg (Extended-Release) Mandatory initiation dose for severe panic disorder and strict tapering/weaning protocols. Venlafaxine Hydrochloride USP/BP/Ph.Eur. 75 mg (Extended-Release) Standard Adult Dose for initiating therapy in Major Depressive Disorder and GAD. Venlafaxine Hydrochloride USP/BP/Ph.Eur. 150 mg (Extended-Release) High-dose SNRI therapy for treatment-resistant depression and severe social anxiety. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 24-hour kinetic release)
Showing the single result
